These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27913142)
1. Candida species from oral cavity of HIV-infected children exhibit reduced virulence factors in the HAART era. Portela MB; Lima de Amorim E; Santos AM; Alexandre da Rocha Curvelo J; de Oliveira Martins K; Capillé CL; Maria de Araújo Soares R; Barbosa de Araújo Castro GF Microb Pathog; 2017 Jan; 102():74-81. PubMed ID: 27913142 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of virulence factors of Candida albicans isolated from HIV-positive individuals using HAART. de Paula Menezes R; de Melo Riceto ÉB; Borges AS; de Brito Röder DV; dos Santos Pedroso R Arch Oral Biol; 2016 Jun; 66():61-5. PubMed ID: 26913969 [TBL] [Abstract][Full Text] [Related]
3. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR]. Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074 [TBL] [Abstract][Full Text] [Related]
4. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. Junqueira JC; Fuchs BB; Muhammed M; Coleman JJ; Suleiman JM; Vilela SF; Costa AC; Rasteiro VM; Jorge AO; Mylonakis E BMC Microbiol; 2011 Nov; 11():247. PubMed ID: 22053894 [TBL] [Abstract][Full Text] [Related]
5. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors. Paula SB; Morey AT; Santos JP; Santos PM; Gameiro DG; Kerbauy G; Sena EM; Ueda LT; Carneiro M; Pinge-Filho P; Yamauchi LM; Yamada-Ogatta SF J Infect Dev Ctries; 2015 Dec; 9(12):1350-9. PubMed ID: 26719941 [TBL] [Abstract][Full Text] [Related]
6. Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis. Villar-Vidal M; Marcos-Arias C; Eraso E; Quindós G Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):660-5. PubMed ID: 21899928 [TBL] [Abstract][Full Text] [Related]
7. Enzyme production by Candida albicans and Candida dubliniensis in periodontal HIV-positive patients receiving and not receiving antiretroviral therapy. Dubois VA; González MI; Martínez ME; Fedelli L; Lamas S; D Eramo LR; Squassi AF; Sánchez GA; Salgado P; Gliosca LA; Molgatini SL Acta Odontol Latinoam; 2020 Sep; 33(2):104-111. PubMed ID: 32920612 [TBL] [Abstract][Full Text] [Related]
8. Biofilm production in oral Candida isolates from HIV-positive individuals from Pune, India. Mane A; Kulkarni A; Risbud A Mycoses; 2013 Mar; 56(2):182-6. PubMed ID: 22931629 [TBL] [Abstract][Full Text] [Related]
9. Protease and phospholipase activities of Candida spp. isolated from cutaneous candidiasis. Ramos Lde S; Barbedo LS; Braga-Silva LA; dos Santos AL; Pinto MR; Sgarbi DB Rev Iberoam Micol; 2015; 32(2):122-5. PubMed ID: 24853474 [TBL] [Abstract][Full Text] [Related]
10. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy. Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023 [TBL] [Abstract][Full Text] [Related]
14. Oral candidiasis of HIV-infected children undergoing sequential HIV therapies. Melo NR; Taguchi H; Culhari VP; Kamei K; Mikami Y; Smith SN; Vilela MS Med Mycol; 2009 Mar; 47(2):149-56. PubMed ID: 18651304 [TBL] [Abstract][Full Text] [Related]
15. Frequency of Candida spp. in the oral cavity of Brazilian HIV-positive patients and correlation with CD4 cell counts and viral load. Back-Brito GN; Mota AJ; Vasconcellos TC; Querido SM; Jorge AO; Reis AS; Balducci I; Koga-Ito CY Mycopathologia; 2009 Feb; 167(2):81-7. PubMed ID: 18781394 [TBL] [Abstract][Full Text] [Related]
16. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. Jin Y; Yip HK; Samaranayake YH; Yau JY; Samaranayake LP J Clin Microbiol; 2003 Jul; 41(7):2961-7. PubMed ID: 12843027 [TBL] [Abstract][Full Text] [Related]
17. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity. Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476 [TBL] [Abstract][Full Text] [Related]
18. Biofilm formation in clinical Candida isolates and its association with virulence. Hasan F; Xess I; Wang X; Jain N; Fries BC Microbes Infect; 2009; 11(8-9):753-61. PubMed ID: 19409507 [TBL] [Abstract][Full Text] [Related]
19. Study of virulence factor of Candida species in oral lesions and its association with potentially malignant and malignant lesions. Castillo GDV; Blanc SL; Sotomayor CE; Azcurra AI Arch Oral Biol; 2018 Jul; 91():35-41. PubMed ID: 29656214 [TBL] [Abstract][Full Text] [Related]
20. High detection of virulence factors by Candida species isolated from bloodstream of patients with candidemia. Nouraei H; Pakshir K; ZareShahrabadi Z; Zomorodian K Microb Pathog; 2020 Dec; 149():104574. PubMed ID: 33075515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]